[(R)-5-allyloxy-2-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)pentyl]carbamic acid tert-butyl ester | 1424402-02-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: [(R)-5-allyloxy-2-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)pentyl]carbamic acid tert-butyl ester
• CAS: 1424402-02-7
• 化学式: C₂₄H₃₄N₂O₆
• 分子量: 446.544
• InChiKey: HPPAGZBEBJLNBW-UXHICEINSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  32.0
• 可旋转键数：
  11.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  94.17
• 氢给体数：
  1.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  [(R)-5-allyloxy-2-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)pentyl]carbamic acid tert-butyl ester 在 哌啶 、 4-二甲氨基吡啶 、 lithium hydroxide monohydrate 、 双氧水 、 碳酸氢钠 、 N,N'-二环己基碳二亚胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 43.0h， 生成 (3S,6R,10R,13E,16S)-10-[(3-chloro-4-methoxyphenyl)methyl]-16-[(2R,3R,4R)-3,4-dihydroxy-4-phenylbutan-2-yl]-3-(2-methylpropyl)-6-(3-prop-2-enoxypropyl)-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone
  参考文献：
  名称：

  Conjugates of Modified Cryptophycins and RGD-Peptides Enter Target Cells by Endocytosis

  摘要：

  Tumor targeting anticancer drug conjugates that contain a tumor recognition motif (homing device) are of high current relevance. Cryptophycins, naturally occurring cytotoxic cyclo-depsipeptides, have been modified by total synthesis to provide analogues suitable for conjugation to peptide-based homing devices. An array of functionalized beta(2)-amino acids was synthesized and incorporated into cryptophycins. All analogues proved to be highly active in the cytotoxicity assay using the human cervix carcinoma cell line KB-3-1 and its multidrug-resistant subclone KB-V1. Conformational analysis of cryptophycin-52 and two synthetic analogues was performed by NMR and MD methods to obtain information on the influence of the unit C configuration on the overall conformation. An azide-functionalized cryptophycin was connected by CuAAC to an alkyne-containing fluorescently labeled cyclic RGD-peptide as the homing device for internalization studies. Confocal fluorescence microscopy proved integrin-mediated internalization by endocytosis and final lysosomal localization of the cryptophycin prodrug.

  DOI：

  10.1021/jm301346z
• 作为产物：
  描述：

  5-(allyloxy)pentanoic acid 在 正丁基锂 、 氯化亚砜 、 sodium hexamethyldisilazane 、 氯甲酸乙酯 、 三乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 39.0h， 生成 [(R)-5-allyloxy-2-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)pentyl]carbamic acid tert-butyl ester
  参考文献：
  名称：

  Conjugates of Modified Cryptophycins and RGD-Peptides Enter Target Cells by Endocytosis

  摘要：

  Tumor targeting anticancer drug conjugates that contain a tumor recognition motif (homing device) are of high current relevance. Cryptophycins, naturally occurring cytotoxic cyclo-depsipeptides, have been modified by total synthesis to provide analogues suitable for conjugation to peptide-based homing devices. An array of functionalized beta(2)-amino acids was synthesized and incorporated into cryptophycins. All analogues proved to be highly active in the cytotoxicity assay using the human cervix carcinoma cell line KB-3-1 and its multidrug-resistant subclone KB-V1. Conformational analysis of cryptophycin-52 and two synthetic analogues was performed by NMR and MD methods to obtain information on the influence of the unit C configuration on the overall conformation. An azide-functionalized cryptophycin was connected by CuAAC to an alkyne-containing fluorescently labeled cyclic RGD-peptide as the homing device for internalization studies. Confocal fluorescence microscopy proved integrin-mediated internalization by endocytosis and final lysosomal localization of the cryptophycin prodrug.

  DOI：

  10.1021/jm301346z